MicroRNA-126 deficiency enhanced the activation and function of CD4⁺ T cells by elevating IRS-1 pathway

Area of Science:

• Immunology
• Molecular Biology
• Cellular Biology

Background:

• MicroRNA-126 (miR-126) is implicated in immune cell development and disease pathogenesis.
• The specific role of miR-126 in CD4+ T cell development and function is largely uncharacterized.

Purpose of the Study:

• To investigate the role of miR-126 in CD4+ T cell activation, proliferation, and function.
• To determine the in vivo impact of miR-126 deficiency on autoimmune colitis.

Main Methods:

• Utilized miRNA-sponge technique to create miR-126 knock-down (KD) CD4+ T cells in vitro.
• Employed a dextran sulphate sodium (DSS)-induced murine model of acute autoimmune colitis.
• Conducted adoptive cell transfer assays with carboxyfluorescein succinimidyl ester (CFSE)-labeled CD4+ T cells.

Main Results:

• miR-126 KD CD4+ T cells exhibited enhanced activation, proliferation, and interferon-gamma (IFN-γ) expression in vitro.
• miR-126 deficiency exacerbated DSS-induced colitis, increasing CD4+ T cell proportion and inflammatory markers (CD69, CD44) while decreasing CD62L.
• Adoptive transfer of miR-126 KD CD4+ T cells worsened colitis pathology and T cell activation compared to wild-type cells.

Conclusions:

• miR-126 acts as an intrinsic regulator of CD4+ T cell function.
• Downregulation of miR-126 promotes CD4+ T cell activation and exacerbates autoimmune colitis.
• Findings provide a basis for exploring miR-126's role in T cell-mediated diseases.